Preterm Premature Rupture of Membrane Clinical Trial
Official title:
Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
The aim of the study is to assess the efficacy of 17-hydroxyprogesterone caproate (17P) therapy on the latency period in pregnant women with Preterm premature rupture of membranes.
After taking informed written consent, the recruited patients will be subjected to the following: 1. Detailed history - Personal History: Name, age ,residence ,special habits of medical importance - Obstetric history: first day of last menstrual period for accurate estimation of gestational age and antenatal care - Past history: history of any medical disorder or surgical history with particular emphasis on prior PPROM or preterm labor - History of the present pregnancy: Medical or surgical condition to define high risk pregnancy. 2. Examination of the patients General examination: blood pressure, pulse, temperature Abdominal examination: - Inspection: fundal level, scars, umbilicus. - Palpation: presence of contractions, fetal lie and presentation. - Pelvic Examination only by sterile speculum to exclude cord prolapse , bloody liquor and cervical dilatation and effacement - Non stress test to ensure reassuring fetal well being - Ultrasound examination to:- - Assess fetal viability. - Amniotic fluid index. - Determine gestational age. - Exclude major anomalies. - Placental location. 3. Baseline laboratory investigations: - Complete blood count (CBC). - Prothrombin time (PT). - Activated partial thromboplastin time (aPTT). - Liver and kidney function. The included patients were randomized using sealed opaque envelope method into one of two groups: Group I (study group): in which 17-hydroxyprogesterone caproate (17P) (250 mg in castor oil, 1 mL total volume, intramuscular injection weekly) will be administered. Group II (control group): in which an identical-appearing placebo (1 mL castor oil only) will be administered. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04963465 -
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Completed |
NCT04294069 -
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
|
Phase 4 | |
| Recruiting |
NCT03976063 -
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
|
Phase 3 | |
| Completed |
NCT01503606 -
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
|
Phase 3 | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Recruiting |
NCT04110704 -
Cerclage After Full Dilatation Caesarean Section
|
N/A | |
| Completed |
NCT03473210 -
The Value of Amniopatch in Preterm Premature Rupture of Membranes
|
N/A | |
| Not yet recruiting |
NCT05328817 -
Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT05353153 -
The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support
|
N/A | |
| Completed |
NCT03814278 -
Bed Rest After Preterm Premature Rupture of the Membranes
|
N/A | |
| Not yet recruiting |
NCT05207800 -
Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
|
||
| Recruiting |
NCT04705935 -
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
|
||
| Active, not recruiting |
NCT06074601 -
MIRACLE of LIFE Study
|
||
| Recruiting |
NCT04516226 -
Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT03306719 -
mtDNA as Novel Biomarker for Intra-amniotic Infection
|
N/A | |
| Completed |
NCT04413019 -
Domiciliary Versus Hospital Management of PPROM
|